Summary
No FDA-approved prescribing information (drug label text/sections) or specific on-label medical claim was provided to evaluate; the statements are about pricing/availability and do not permit label alignment assessment.
Category Scores
Accurate Statements
Unsupported Statements
Clobetasol pricing varies depending on formulation (cream, ointment, solution, lotion, shampoo), strength, package size, whether the product is generic or branded, and pharmacy, insurance coverage, and location.
No FDA label prescribing information was provided to assess pricing-related claims.
Clobetasol is widely available as a generic.
No FDA label prescribing information was provided to assess market availability claims.
Generic clobetasol products are usually priced substantially lower than branded equivalents.
No FDA label prescribing information was provided to assess pricing comparisons.
The price difference between generic and brand-name clobetasol is often tied to brand vs generic labeling, different vehicle (ointment vs cream vs solution), prescription quantity (days supply), and whether the drug is billed under a particular formulary tier.
No FDA label prescribing information was provided to assess drivers of pricing/formulary billing.
Clobetasol comes in multiple vehicles (dosage forms).
No FDA label prescribing information was provided to verify approved dosage forms.
Pricing differs because each clobetasol product is treated as a different SKU (strength plus dosage form plus package size).
No FDA label prescribing information was provided to assess SKU/pricing structure.
Even with the same strength (e.g., 0.05%), the ointment and the cream may cost differently at the same pharmacy.
No FDA label prescribing information was provided to assess relative prices by vehicle.
Clobetasol is an older corticosteroid.
No FDA label prescribing information was provided to assess historical age/timeline.
Many market price fluctuations for clobetasol are driven by availability of generics, pharmacy pricing, and insurance coverage rather than new patent exclusivity.
No FDA label prescribing information was provided to assess reasons for market price fluctuations.
DrugPatentWatch.com tracks drug patent and litigation information across brands and generics.
No FDA label prescribing information was provided to assess external website functionality.
DrugPatentWatch.com has information for clobetasol.
No FDA label prescribing information was provided to verify external site content.
To get an accurate current price for clobetasol, information such as dosage form, strength, size, ZIP code (or pharmacy used), and whether cash price or an insurance copay is needed is required.
No FDA label prescribing information was provided to assess pricing-information requirements.
Contradictions
Low
AI Statement
Clobetasol comes in multiple vehicles (dosage forms).
Label Reference
Not assessable: no FDA label text/sections were provided to verify approved dosage forms.
Important Omissions
FDA-approved prescribing information (label text/sections) and/or the exact on-label medical claim to compare against (e.g., indication, dosing, warnings).
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
The provided statements are about pricing/availability and do not include dosing, contraindications, or safety claims that could be directly assessed against the label.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Auditable
Primary Issue
No FDA label text/sections and no specific medical claim were provided; only pricing/market statements were given.
Suggested Improvement
Provide the relevant FDA-approved label sections (e.g., Indications and Usage, Dosage and Administration, Contraindications, Warnings and Precautions, Adverse Reactions, Drug Interactions, Use in Specific Populations) and the exact AI-generated medical claim(s) to evaluate verbatim.